Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramalingam

Showing results (201-210 of 502) with videos related to

Pageof 51
Sort By:
Annual Review of Medicine|February 8, 2018
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for InterventionsMasao Hashimoto, Alice O Kamphorst, Se Jin Im, et al.
Cancer|September 26, 2008
Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 studyChandra P Belani, Marshall T Schreeder, Ronald G Steis, et al.
Cancer Research|November 8, 2013
Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductaseMaohua Xie, Yun Yen, Taofeek K Owonikoko, et al.
Cancer Gene Therapy|April 22, 2022
Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1Yunfu Deng, Guangzhi Ma, Karin A Vallega, et al.
JAMA Oncology|August 28, 2015
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based CostDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
The Indian Journal of Medical Research|April 9, 2005
Subtype & cytokine profiles of HIV infected individuals from south IndiaS Ramalingam, R Kannangai, T S Vijayakumar, et al.
Cancer|August 8, 2013
Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancerBree R Eaton, Sungjin Kim, David M Marcus, et al.
Cell Death and Differentiation|April 29, 2014
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosisB Wang, M Xie, R Li, et al.
Molecular Cancer|May 22, 2020
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer TherapyKe Xu, Dongkyoo Park, Andrew T Magis, et al.
The Indian Journal of Medical Research|January 31, 2002
A pilot study of HTLV-I infection in high-risk individuals & their family members from IndiaS Ramalingam, R Kannangai, K J Prakash, et al.
Pageof 51

Showing results (201-210 of 502) with videos related to

Sort By:
Pageof 51
Annual Review of Medicine|February 8, 2018
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for InterventionsMasao Hashimoto, Alice O Kamphorst, Se Jin Im, et al.
Cancer|September 26, 2008
Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 studyChandra P Belani, Marshall T Schreeder, Ronald G Steis, et al.
Cancer Research|November 8, 2013
Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductaseMaohua Xie, Yun Yen, Taofeek K Owonikoko, et al.
Cancer Gene Therapy|April 22, 2022
Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1Yunfu Deng, Guangzhi Ma, Karin A Vallega, et al.
JAMA Oncology|August 28, 2015
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based CostDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
The Indian Journal of Medical Research|April 9, 2005
Subtype & cytokine profiles of HIV infected individuals from south IndiaS Ramalingam, R Kannangai, T S Vijayakumar, et al.
Cancer|August 8, 2013
Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancerBree R Eaton, Sungjin Kim, David M Marcus, et al.
Cell Death and Differentiation|April 29, 2014
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosisB Wang, M Xie, R Li, et al.
Molecular Cancer|May 22, 2020
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer TherapyKe Xu, Dongkyoo Park, Andrew T Magis, et al.
The Indian Journal of Medical Research|January 31, 2002
A pilot study of HTLV-I infection in high-risk individuals & their family members from IndiaS Ramalingam, R Kannangai, K J Prakash, et al.
Pageof 51